| Financial Year |
March 31 2023 |
| Monetary Funds |
163,770,114.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
40,210,404.96 |
| Accounts Receivable |
276,722,887.06 |
| Advances to Suppliers |
156,611,322.47 |
| Other Receivables |
62,873,888.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
61,698,121.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,125,852.90 |
| Total Current Assets |
817,900,582.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,125,058.90 |
| Investment Properties |
115,852,567.59 |
| Fixed Assetes |
43,514,946.18 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
662,772.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
742,100.27 |
| Deferred Income Tax Assets |
9,327,006.14 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
208,940,805.09 |
| Total Assets |
1,026,841,387.24 |
| Short-Term Loans |
321,352,190.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
22,671,595.92 |
| Accounts Received In Advance |
2,049,642.17 |
| Employee Compensation Payable |
5,501,199.11 |
| Taxes Payable |
5,557,166.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,179,773.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,547.40 |
| Other Current Liabilities |
4,464,923.20 |
| Sub-Total of Current Liabilities |
413,094,120.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,505,700.90 |
| Total Liabilities |
446,599,821.06 |
| Paid-In Capital(Or Share Stock) |
108,752,191.00 |
| Capital Surplus |
164,545,702.59 |
| Surplus Reserve |
31,061,477.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
253,019,695.08 |
| Minority Stockholder's Interest |
22,851,917.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
557,389,648.67 |
| Owner's Equity（Stockholder's Equity） |
580,241,566.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,026,841,387.24 |
